|
|
Euglobulin Lysis Time
Alternate Names : Euglobulin Clot Lysis, Fibrinolysis/Euglobulin Lysis
What do Abnormal Results Mean?
In primary fibrinolysis (for example, caused by streptokinase administration, cancer of the prostate, shock), the euglobulin lysis time is shorter than normal.
In DIC, it is usually normal, but if all the plasmin has been consumed, the time may be prolonged.
- Decreased fibrinolysis (increased lysis time) may indicate:
- Increased fibrinolysis (shortened lysis time) may indicate:
Additional conditions under which the test may be performed:
Today's Top News Stories | | Falls Are Top Cause of Injury, Death Among Elderly - Jul 19, 2008, 09:00 Not all homes are the same, but common sense measures can reduce the risk, expert says. | | Heart Blood Vessels Grown in the Lab - Jul 18, 2008, 19:00 Could offer a future alternative to bypass surgery, researchers say. | | Clinical Trials Update: July 18, 2008 - Jul 18, 2008, 09:24
- Breast Cancer
- Hot Flashes
- Emphysema
| | Loud Music in Bars Hastens Drinking - Jul 18, 2008, 16:00 French researchers say blasting tunes makes patrons down more alcohol in less time. | | Breast-Fed Babies Have Fewer GI Infections - Jul 18, 2008, 17:00 But they're more likely to be iron-deficient, study finds. |
|
Jump to another section
Definition Why is the Test Performed? How is the Test Performed? How to Prepare for the Test? How will the Test Feel? Normal Values What do Abnormal Results Mean? Special Considerations Risks
Topics that might be of interest to you Diseases & Conditions
Abortion - Spontaneous Blood Clots Cirrhosis Diabetes DIC (Disseminated Intravascular Coagulation) Heart Attack Hydatidiform Mole Premature Infant Primary or Secondary Fibrinolysis Prostate Cancer
Tests & Exams
Blood Pressure Fibrinogen Venipuncture
Other Topics
Adolescent Test or Procedure Preparation Bleeding Fainting Infant Test/Procedure Preparation Preschooler Test/Procedure Preparation School Age Test/Procedure Preparation Shock Toddler Test/Procedure Preparation
Review Date : 5/8/2003
Reviewed By : Marcia S. Brose, M.D., Ph.D., Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
|
|